Evidence map›Paper›PMID 23243281›Full record

ArticleBlood2013

Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection.

Edwin Leeansyah, Anupama Ganesh, Máire F Quigley, Anders Sönnerborg, Jan Andersson, Peter W Hunt, Ma Somsouk, Steven G Deeks, Jeffrey N Martin, Markus Moll and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05598346 (Significance and Biological Importance of Mucosal Associated Invariant T Cells in Inflammatory Bowel Disease Patients), which is not on this map. Cited by 244 papers.

0numbers the graph read from it
0cells of the map it votes in
244citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05598346 unknown statusnot on this mapstarted 2023, after this paper: background citation

Significance and Biological Importance of Mucosal Associated Invariant T Cells in Inflammatory Bowel Disease Patients

TypeobservationalSponsorAssiut UniversityRan2023 to 2024Enrolled70ConditionsInflammatory Bowel Diseases
3 · Its place in the literature

Who cites it

244 citing papers in PubMed, 370 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Gastrointestinal MAIT cells in chronic HIV-1 infection.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

184 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Edwin LeeansyahCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. edwin.leeansyah@ki.se
Anupama Ganesh
Máire F Quigley
Anders Sönnerborg
Jan Andersson
Peter W Hunt
Ma Somsouk
Steven G Deeks
Jeffrey N Martin
Markus Moll
Barbara L Shacklett
Johan K Sandberg
Karolinska Institutet · SEKarolinska University Hospital · SEUniversity of California, San Francisco · USUniversity of California Davis Medical Center · USSan Francisco General Hospital · US

Funding

UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
Specimen Acquisition and Distribution CoreP01AI076174 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEDERMAN, MICHAEL MARCEL · 2008 to 2012
$10.9M
HIV-Specific T Cell Responses in Rectal MucosaR01AI057020 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SHACKLETT, BARBARA L. · 2003 to 2016
$6.2M
The impact of early antiretroviral therapy on HIV persistence and inflammationR01AI087145 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2009 to 2010
$1.6M
Preventing the Establishment of Enfuvirtide-resistance in the Latent ReservoirK24AI069994 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEEKS, STEVEN GRANT · 2007 to 2016
$1.5M
HIV, Gut Mucosal Turnover and Inflammation, and the Risk of Colorectal NeoplasiaK23CA157929 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SOMSOUK, MA · 2011 to 2014
$687k
NCI NIH HHS K23 CA157929NCRR NIH HHS UL1 RR024131NCRR NIH HHS UL1-RR024131NIAID NIH HHS K24 AI069994NIAID NIH HHS K24-AI069994NIAID NIH HHS P01-AI027763NIAID NIH HHS P01 AI076174NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI057020NIAID NIH HHS R01-AI057020NIAID NIH HHS R01-AI076174NIAID NIH HHS R01 AI087145NIAID NIH HHS R01-AI087145NIAID NIH HHS R24 AI067039NIAID NIH HHS R24-AI067039NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

Mucosal-associated invariant T (MAIT) cells are an evolutionarily conserved antimicrobial MR1-restricted T-cell subset. MAIT cells are CD161(+), express a V7.2 TCR, are primarily CD8(+) and numerous in blood and mucosal tissues. However, their role in HIV-1 infection is unknown. In this study, we found levels of MAIT cells to be severely reduced in circulation in patients with chronic HIV-1 infection. Residual MAIT cells were highly activated and functionally exhausted. Their decline was associated with time since diagnosis, activation levels, and the concomitant expansion of a subset of functionally impaired CD161(+) V7.2(+) T cells. Such cells were generated in vitro by exposure of MAIT cells to Escherichia coli. Notably, whereas the function of residual MAIT cells was at least partly restored by effective antiretroviral therapy, levels of MAIT cells in peripheral blood were not restored. Interestingly, MAIT cells in rectal mucosa were relatively preserved, although some of the changes seen in blood were recapitulated in the mucosa. These findings are consistent with a model in which the MAIT-cell compartment, possibly as a result of persistent exposure to microbial material, is engaged, activated, exhausted, and progressively and persistently depleted during chronic HIV-1 infection.

Indexed as

HIV-1AdultAntiretroviral Therapy, Highly ActiveEscherichia coliFemaleHistocompatibility Antigens Class IHIV InfectionsHumansImmunity, MucosalIntestinal MucosaLymphocyte ActivationLymphopeniaMaleMiddle AgedMinor Histocompatibility AntigensNK Cell Lectin-Like Receptor Subfamily BHistocompatibility Antigens Class IKLRB1 protein, humanMinor Histocompatibility AntigensMR1 protein, humanNK Cell Lectin-Like Receptor Subfamily BReceptors, Antigen, T-Cell

Identifiers

PMID23243281
PMCPMC3575756
OpenAlexW1994087084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.